Skip to main content
. Author manuscript; available in PMC: 2015 Aug 24.
Published in final edited form as: Toxicol Appl Pharmacol. 2015 Jan 3;284(2):262–272. doi: 10.1016/j.taap.2014.12.014

Table 5.

Comparison of the performance of QSAR models with that of skin sensitization module of VEGA.

Sensitivity PPV Specificity NPV CCR
Model 5 - Consensus 0.84 0.90 0.75 0.63 0.80
VEGA 0.93 0.78 0.25 0.57 0.59

NB. Applicability domain was not considered for model 5